A phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis: Induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (IDREAM) study
A phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis: Induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (IDREAM) study
复制标题
伯舒替尼治疗肌萎缩侧索硬化症的 I 期剂量递增研究：基于诱导多能干细胞的药物再利用用于肌萎缩侧索硬化症药物 (IDREAM) 研究
DOI：
--
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Ryosuke Takahashi
中科院分区：
文献类型：
--
作者：
Haruhisa Inoue;Keiko Imamura;Yuishin Izumi;Makiko Nagai;Kazutoshi Nishiyama;Yasuhiro Watanabe;Ritsuko Hanajima;Naohiro Egawa;Takashi Ayaki;Ryosuke Oki;Koji Fujita;Akiko Morinaga;Tomoko Hirohashi;Yosuke Fujii;Satoshi Morita;Ryosuke Takahashi
